🏅 FDA Orphan Designation

Intron A

Interferon alfa-2b (recombinant)

Manufacturer: Schering Corporation

Indicated for:

OBSOLETE: HIV-related Kaposi sarcomaOrphan

FDA-Approved Indications (1)

OBSOLETE: HIV-related Kaposi sarcomaOrphan Designation

Treatment of selected patients with AIDS-related Kaposi's sarcoma.

Indications & Usage

Treatment of selected patients with AIDS-related Kaposi's sarcoma.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.